2007
DOI: 10.2533/chimia.2007.199
|View full text |Cite
|
Sign up to set email alerts
|

Does A.M. Have a Tumour in the Pancreas?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…The adjunctive use of neuromuscular blocking drugs makes it possible to achieve an adequate muscle relaxation for all types of surgical procedures without the cardiorespiratory depressant effects of deep anesthesia [1][2][3]. Several analytical methods have been reported for the analysis of VB in biological fluids and pharmaceutical preparations, and these include LC-MS [4][5][6][7][8][9], LC with electrochemical detection [10,11], LC by using solid phase extraction with post-column ion-pair extraction and fluorimetric detection [12], and capillary gas chromatography by using nitrogen sensitive detection [13]. Its final degradation product (3,17-desacetyl vecuronium) is via hydrolysis hence the aim of this research was to develop and validate two simple and reliable analytical methods for the quantitative determination of VB in pharmaceuticals by separating its final degradation product as well as to compare the performance of chromatographic and electrophoretic techniques.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The adjunctive use of neuromuscular blocking drugs makes it possible to achieve an adequate muscle relaxation for all types of surgical procedures without the cardiorespiratory depressant effects of deep anesthesia [1][2][3]. Several analytical methods have been reported for the analysis of VB in biological fluids and pharmaceutical preparations, and these include LC-MS [4][5][6][7][8][9], LC with electrochemical detection [10,11], LC by using solid phase extraction with post-column ion-pair extraction and fluorimetric detection [12], and capillary gas chromatography by using nitrogen sensitive detection [13]. Its final degradation product (3,17-desacetyl vecuronium) is via hydrolysis hence the aim of this research was to develop and validate two simple and reliable analytical methods for the quantitative determination of VB in pharmaceuticals by separating its final degradation product as well as to compare the performance of chromatographic and electrophoretic techniques.…”
Section: Introductionmentioning
confidence: 99%
“…Vecuronium bromide (VB) is a nondepolarizing neuromuscular blocking agent; it is chemically designated as [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-Acetyloxy-10, 13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2, 3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide. VB presents all pharmacological actions of the curare, in addition; this drug interferes in the transmission of neuromuscular end plate and causes diminished central nervous system activity.…”
Section: Introductionmentioning
confidence: 99%
“…Electrospray ionization is a suitable technique for the detection of the compounds which have the lack of volatility, thermal stability, and the presence of quaternary amine moieties [11][12][13][14][15][16][17][18][19]. Therefore, it is very suitable to use ESI-MS technique for determination of CHD and NPEOn.…”
Section: Introductionmentioning
confidence: 98%